A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening
K. Gorshkov, D. M. Vasquez, K. Chiem, C. Ye, B. Nguyen Tran, J. C. de la Torre, T. Moran, C. Z. Chen, L. Martinez-Sobrido, W. Zheng
The paper develops a TR-FRET assay for SARS-CoV-2 NP detection, enabling high-throughput screening of compounds against SARS-CoV-2 and its variants.
bioRxiv · Jul 3, 2021Pharmacology & Toxicology